The Association between CHA2DS2-VASc Score and Mortality in Patients with Heart Failure with Reduced Ejection Fraction.
Acta Cardiol Sin
; 33(4): 429-435, 2017 Jul.
Article
in En
| MEDLINE
| ID: mdl-29033514
ABSTRACT
BACKGROUND:
Heart failure (HF) is associated with significant mortality and morbidity. Therefore, identifying high-risk patients may optimize treatment for HF patients and reduce adverse events. The aim of this study was to assess the role of the CHA2DS2-VASc score to predict mortality in patients with reduced left ventricular ejection fraction (LVEF).METHODS:
A total of 106 patients with reduced LVEF were enrolled in this study. All patients completed a one-year follow-up, and a CHA2DS2-VASc score was calculated for each patient.RESULTS:
Twenty-one patients (19.8%) died during the 1-year follow-up. We found that baseline functional status, CHA2DS2-VASc score, brain natriuretic peptide, blood urea and hemoglobin levels were associated with mortality. In the multivariate analysis, CHA2DS2-VASc score and functional capacity were the only predictors of 1-year mortality.CONCLUSIONS:
Use of the CHA2DS2-VASc score appears to be feasible for risk stratification and mortality prediction in patients with reduced LVEF.
Full text:
1
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Acta Cardiol Sin
Year:
2017
Type:
Article
Affiliation country:
Turkey